ZeptoMetrix Corporation NATtrol™ Clostridium difficile NAP1 External Run Controls Available on GSA/VA Contract for Federal Government customers only.

Formulated with purified, intact chemically modified bacterial cells to render them non-infectious and refrigerator stable

Manufacturer: ZeptoMetrix CorporationSupplier Diversity Partner NATCDI(NAP1)ERCM

 View more versions of this product

Catalog No. 22-156-712

  Check Availability
Add to Cart

    Specifications

    Biosafety Level 2
    Certifications/Compliance ISO, 13485
    Concentration 28 to 31 Ct
    For Use With (Application) Controls are full process controls designed to validate the extraction and amplification of C. difficile in Human stool samples
    Format Solution
    Formulation Formulated with purified, intact bacterial cells
    Media Type Vial
    Product Type NATtrol™ Clostridium difficile NAP1 external run control
    Quantity 6 x 1mL
    Storage Requirements -65°C

    • Each control pack contains 6 x 1.0mL vials of C. difficile NATtrol™ at concentrations 28 to 34 Ct Range
    • Supplied in purified protein matrix identical to the composition of true clinical specimen
    • Designed to evaluate the performance of nucleic acid tests for determination of the presence of C. difficile DNA

    Contain intact organisms and should be run in a manner identical to that used for clinical specimens.

    Validation of clinical assays, development of diagnostic tests and training of laboratory personnel

  • Description & Specifications

Related Products


Product Content Feedback

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit